Financial Summary Q3'21

Balance Sheet / Balance General
PEN MM
InRetail - Consolidated Balance Sheet

As of September 30, 2021 and December 31, 2020 (audited)
InRetail - Balance General Consolidado
Al 30 de setiembre, 2021 y al 31 de diciembre, 2020 (auditado)
Assets
Cash and short-term deposits
Investments at fair value through profit or loss
Inventories, net
Other current assets
Property, furniture and equipment
Right-of-use asset
Investment properties
Intangible assets
Other non current assets
Total assets
Liabilities
Short- term debt
Other short-term liabilities
Long-term debt
Other long-term liabilities
Total liabilities
Total equity
Total net equity and liabilities
InRetail Pharma - Balance Sheet

InRetail Pharma - Balance General
Assets
Inventories, net
Investments at fair value through equity
Right-of-use asset
Intangible assets
Total assets
Liabilities
Short- term debt
Long-term debt
Total liabilities
Total equity
InRetail Shopping Malls - Balance Sheet

InRetail Shopping Malls - Balance General
Assets
Investments at fair value through profit or loss
Investments at fair value through equity
Right-of-use asset
Investment in associates
Intangible assets
Total assets
Liabilities
Short- term debt
Long-term debt
Total liabilities
Total equity
As of Sep 30 2021
Al 30 set 2021
Activos
Efectivo y equivalente de efectivo 963
Inversiones a valor razonable con cambios en resultados 2
Existencias 2,622
Otros activos corrientes 1,153
Inmuebles, mobiliario y equipo, neto 4,404
Activo por derecho de uso 1,336
Propiedades de inversión 3,994
Activos intangibles, neto 3,888
Otros activos no corrientes 739
Total activos 19,102
Pasivos
Obligaciones financieras de corto plazo 542
Otros pasivos de corto plazo 4,862
Obligaciones financieras de largo plazo 7,316
Otros pasivos de largo plazo 2,208
Total pasivos 14,928
Total patrimonio 4,174
Total pasivo y patrimonio 19,102
As of Sep 30 2021
Al 30 set 2021
Activos
Existencias 1,418
Otros activos corrientes 997
Inversiones a valor razonable con cambios en patrimonio 178
Inmuebles, mobiliario y equipo, neto 599
Activo por derecho de uso 534
Propiedades de inversión -
Activos intangibles, neto 1,852
Total activos 5,992
Pasivo
Otros pasivos de corto plazo 2,234
Obligaciones financieras de largo plazo 991
Otros pasivos de largo plazo 2,052
Total pasivos 5,475
Total patrimonio 517
As of Sep 30 2021
Al 30 set 2021
Activos
Inversiones a valor razonable con cambios en resultados 2
Inversiones a valor razonable con cambios en patrimonio 189
Otros activos corrientes 107
Inmuebles, mobiliario y equipo, neto 11
Activo por derecho de uso 135
Propiedades de inversión 4,328
Inversión en asociadas -
Activos intangibles, neto 12
Total activos 5,615
Pasivo
Otros pasivos de corto plazo 96
Obligaciones financieras de largo plazo 2,225
Otros pasivos de largo plazo 639
Total pasivos 3,121
Total patrimonio 2,494
As of Dec 31 2020
Al 31 dic 2020
936
242
2,159
1,000
4,267
1,394
3,900
3,927
435
18,259
1,774
4,334
5,243
2,194
13,545
4,714
18,259
As of Dec 31 2020
Al 31 dic 2020
550
1,187
694
54
571
573
-
1,940
235
5,804
190
2,087
2,034
678
4,989
815
5,804
As of Dec 31 2020
Al 31 dic 2020
20
149
194
94
12
137
4,224
-
11
585
5,426
101
126
2,095
666
2,988
-
2,438
-
5,426
Income Statement / Estado de Resultados
PEN MM
InRetail - Consolidated Income Statement

InRetail - Estado de Resultados Consolidado
Revenues Ingresos
Cost of Sales Costo de Ventas
Gross Profit Utilidad Bruta
Gross Margin Margen Bruto
Selling and Administrative Expenses Gasto de Ventas y Administración
Other income (expenses) net Otros ingresos (gastos), neto
Operating Profit Utilidad Operativa
Operating Margin Margen Operativo
Financial income (expenses) net Ingresos (gastos) financieros, neto
Income tax expense Impuesto a la Renta
Net Income Utilidad Neta
Net Margin Margen Neto
Adj. EBITDA EBITDA Ajus.
Adj. EBITDA Margin Margen EBITDA Ajust.
InRetail Pharma - Income Statement

InRetail Pharma - Estado de Resultados
Revenues Ingresos
Selling and Administratives Expenses Gasto de Ventas y Administración
Adj. EBITDA Margin Margen EBITDA Ajus.
InRetail Shopping Malls - Income Statement

InRetail Shopping Malls - Estado de Resultados
Revenues Ingresos
Selling and Administratives Expenses Gasto de Ventas y Administración
Adj. EBITDA Margin Margen EBITDA Ajus.
m
1Q15 2Q15 3Q15 4Q15 2015 1Q16 2Q16

1T15 2T15 3T15 4T15 1T16 2T16
1,611 1,645 1,674 1,868 6,798 1,765 1,746

-1,131 -1,146 -1,173 -1,293 -4,742 -1,234 -1,206
481 499 501 575 2,056 530 541
29.8% 0.0% 30.0% 30.8% 30.2% 30.0% 31.0%
-353 -370 -372 -404 -1,499 -394 -401
4 9 5 21 40 2 4
132 138 134 192 597 139 145
8.2% 0.0% 8.0% 10.3% 8.8% 7.8% 8.3%
-108 -91 -96 -89 -385 -38 -46
-14 -31 -19 -4 -68 -36 -35
10 16 19 99 144 64 64
0.6% 0.0% 1.2% 5.3% 2.1% 3.6% 3.6%
163 170 170 219 724 180 185
10.1% 0.0% 10.2% 11.7% 10.7% 10.2% 10.6%
1Q15 2Q15 3Q15 4Q15 1Q16 2Q16

2015
1T15 2T15 3T15 4T15 1T16 2T16
1Q15 2Q15 3Q15 4Q15 1Q16 2Q16
2015
1T15 2T15 3T15 4T15 1T16 2T16
103 106 108 118 435 108 111

-32 -33 -32 -38 -135 -34 -34
71 73 77 80 301 74 77
68.7% 68.7% 70.8% 68.1% 69.1% 68.5% 69.4%
-8 -8 -9 -8 -33 -8 -7
6 7 3 17 34 1 3
69 73 71 89 301 66 72
67.0% 68.4% 65.4% 75.5% 69.3% 61.5% 65.3%
-52 -47 -42 -43 -184 -22 -24
-4 -13 -3 13 -7 -13 -15
13 12 26 59 110 31 34
12.5% 11.6% 23.8% 49.8% 25.2% 28.4% 30.5%
63 66 67 73 272 67 71
82.9% 83.2% 81.3% 80.7% 82.8% 82.1% 83.1%
3Q16 4Q16 2016 1Q17 2Q17 3Q17 4Q17
3T16 4T16 1T17 2T17 3T17 4T17
1,794 1,968 7,273 1,913 1,865 1,912 2,120

-1,237 -1,342 -5,019 -1,345 -1,291 -1,319 -1,461
557 626 2,254 568 575 592 658
31.1% 31.8% 31.0% 29.7% 30.8% 31.0% 31.1%
-413 -442 -1,649 -428 -435 -441 -463
13 10 29 7 4 4 23
157 193 634 147 143 156 219
8.8% 9.8% 8.7% 7.7% 7.7% 8.1% 10.3%
-74 -48 -206 -34 -52 -54 -52
-34 -54 -160 -40 -43 -40 -64
49 91 268 73 48 63 102
2.7% 4.6% 3.7% 3.8% 2.6% 3.3% 4.8%
196 232 793 188 187 200 250
10.9% 11.8% 10.9% 9.8% 10.0% 10.5% 11.8%
3Q16 4Q16 1Q17 2Q17 3Q17 4Q17

2016
3T16 4T16 1T17 2T17 3T17 4T17
662 661 705 705

-449 -439 -473 -471
213 222 232 234
32.1% 33.6% 32.9% 33.2%
-171 -178 -181 -184
-1 -1 0 -2
41 43 52 48
6.2% 6.5% 7.3% 6.8%
-1 -0 2 -0
-12 -14 -17 -15
28 29 37 33
4.2% 4.3% 5.3% 4.6%
52 54 63 62
7.8% 8.2% 8.9% 8.7%
3Q16 4Q16 1Q17 2Q17 3Q17 4Q17

2016
3T16 4T16 1T17 2T17 3T17 4T17
114 125 458 112 118 117 129

-34 -41 -143 -38 -41 -36 -42
80 84 315 73 78 81 87
70.3% 67.0% 68.8% 65.5% 65.8% 69.4% 67.4%
-8 -9 -33 -8 -8 -10 -11
5 3 12 4 2 1 12
78 77 294 70 71 73 87
68.2% 61.7% 64.1% 62.6% 60.2% 62.5% 67.9%
-39 -25 -110 -20 -27 -27 -25
-12 -16 -56 -15 -15 -15 -21
28 36 128 35 30 31 41
24.2% 28.8% 27.9% 31.2% 25.3% 26.4% 32.2%
74 75 286 67 71 73 82
83.1% 80.1% 82.1% 79.3% 81.0% 79.5% 83.4%
Excludes IFR
Excluye efec
2017 1Q18 2Q18 3Q18 4Q18 2018 1Q19
1T18 2T18 3T18 4T18 1T19
7,810 2,711 3,095 3,091 3,346 12,243 3,249

-5,416 -1,931 -2,216 -2,158 -2,366 -8,671 -2,298
2,394 780 878 933 980 3,572 952
30.7% 28.8% 28.4% 30.2% 29.3% 29.2% 29.3%
-1,767 -622 -683 -661 -700 -2,666 -712
39 17 33 -23 7 33 13
665 174 228 250 286 939 253
8.5% 6.4% 7.4% 8.1% 8.6% 7.7% 7.8%
-192 -154 -184 -86 -94 -517 -85
-187 -42 -29 -63 -63 -197 -58
286 -21 15 101 130 225 111
3.7% 2.6% 0.5% 3.3% 3.9% 1.8% 3.4%
825 226 272 318 367 1,183 321
10.6% 8.3% 8.8% 10.3% 11.0% 9.7% 9.9%
Excludes IFR
Excluye efec
1Q18 2Q18 3Q18 4Q18 1Q19
2017 2018
1T18 2T18 3T18 4T18 1T19
2,734 1,379 1,777 1,777 1,770 6,704 1,705

-1,833 -975 -1,287 -1,240 -1,267 -4,769 -1,187
901 404 490 537 503 1,935 518
33.0% 29.3% 27.6% 30.2% 28.4% 28.9% 30.4%
-713 -355 -400 -371 -378 -1,504 -389
-5 9 13 -21 -5 -5 0
184 58 103 145 120 426 129
6.7% 4.2% 5.8% 8.2% 6.8% 6.4% 7.6%
1 -26 -91 -28 -36 -182 -34
-59 -17 -7 -40 -26 -90 -26
126 15 5 77 58 155 68.9
4.6% 1.1% 0.3% 4.3% 3.3% 2.3% 4.0%
231 78 126 168 168 540 159
8.4% 5.7% 7.1% 9.5% 9.5% 8.1% 9.3%
Excludes IFR
Excluye efec
1Q18 2Q18 3Q18 4Q18 1Q19
2017 2018
1T18 2T18 3T18 4T18 1T19
476 122 124 124 138 508 127

-157 -39 -41 -40 -45 -165 -43
319 83 83 84 93 343 84
67.0% 67.8% 67.0% 67.6% 67.4% 67.5% 65.8%
-36 -10 -10 -10 -11 -41 -9
19 5 6 4 9 23 3
302 78 79 77 91 325 78
63.4% 64.0% 63.7% 62.6% 65.6% 64.0% 61.3%
-99 -34 -59 -31 -26 -150 -25
-66 -11 -8 -14 -18 -52 -16
137 33 12 32 47 123 37
28.8% 26.8% 9.6% 26.1% 33.6% 24.3% 28.8%
294 76 74 75 85 311 76
80.9% 80.7% 79.0% 78.9% 80.0% 79.6% 78.5%
Excludes IFRS 16 effect Includes IFRS 16 effect
Excluye efecto NIIF 16 Incluye efecto NIIF 16
2Q19 3Q19 4Q19 2019 1Q19 2Q19 3Q19
2T19 3T19 4T19 1T19 2T19 3T19
3,156 3,221 3,444 13,070 3,249 3,156 3,221

-2,209 -2,242 -2,378 -9,126 -2,296 -2,208 -2,240
947 979 1,066 3,944 953 948 981
30.0% 30.4% 31.0% 30.2% 29.3% 30.0% 30.5%
-704 -709 -704 -2,829 -708 -687 -700
18 25 131 187 13 18 25
261 294 494 1,302 258 280 305
8.3% 9.1% 14.3% 10.0% 7.9% 8.9% 9.5%
-83 -91 -89 -348 -96 -97 -138
-68 -61 -144 -330 -56 -70 -60
110 143 260 624 106 112 107
3.5% 4.4% 7.6% 4.8% 3.3% 3.6% 3.3%
324 352 429 1,427 399 414 442
10.3% 10.9% 12.5% 10.9% 12.3% 13.1% 13.7%

2Q19 3Q19 4Q19 1Q19 2Q19 3Q19
2019
2T19 3T19 4T19 1T19 2T19 3T19
1,688 1,719 1,740 6,852 1,705 1,688 1,719

-1,177 -1,179 -1,179 -4,722 -1,187 -1,177 -1,179
511 540 561 2,130 518 511 540
30.3% 31.4% 32.3% 31.1% 30.4% 30.3% 31.4%
-378 -384 -385 -1,537 -385 -375 -376
1 0 5 6 0 1 0
133 156 181 599 133 137 165
7.9% 9.1% 10.4% 8.7% 7.8% 8.1% 9.6%
-32 -32 -36 -134 -38 -42 -58
-31 -40 -53 -151 -26 -33 -38
70.4 83 92 315 69 62 68
4.2% 4.9% 5.3% 4.6% 4.1% 3.7% 4.0%
161 185 206 711 214 223 255
9.5% 10.7% 11.8% 10.4% 12.5% 13.2% 14.8%

2Q19 3Q19 4Q19 1Q19 2Q19 3Q19
2019
2T19 3T19 4T19 1T19 2T19 3T19
130 132 154 543 127 130 132

-43 -44 -50 -181 -42 -42 -42
87 88 104 362 85 88 90
66.8% 66.8% 67.4% 66.8% 66.7% 67.7% 68.2%
-10 -10 -12 -42 -9 -10 -10
4 12 158 177 3 4 12
81 90 249 498 79 82 92
62.1% 68.2% 161.8% 91.7% 62.2% 62.9% 69.6%
-25 -28 -31 -109 -25 -26 -34
-18 -17 -70 -120 -16 -17 -17
38 45 148 268 38 39 40
29.4% 34.5% 95.9% 49.4% 29.5% 30.2% 30.7%
78 79 93 325 79 81 82
78.0% 77.6% 79.6% 78.5% 81.6% 81.1% 81.3%
es IFRS 16 effect Includes IFRS 16 effect
e efecto NIIF 16 Incluye efecto NIIF 16
4Q19 2019 1Q20 2Q20 3Q20 4Q20 2020
4T19 1T20 2T20 3T20 4T20
3,444 13,070 3,406 3,368 3,701 3,934 14,409

-2,378 -9,122 -2,414 -2,431 -2,632 -2,763 -10,241
1,066 3,948 993 936 1,069 1,171 4,169
31.0% 30.2% 29.1% 27.8% 28.9% 29.8% 28.9%
-695 -2,790 -713 -707 -737 -794 -2,952
131 187 13 -42 -2 -57 -88
501 1,345 293 187 330 319 1,129
14.6% 10.3% 8.6% 5.5% 8.9% 8.1% 7.8%
-95 -427 -151 -146 -140 -142 -578
-135 -321 -50 -29 -69 -63 -211
271 597 92 12 122 114 339
7.9% 4.6% 2.7% 0.3% 3.3% 2.9% 2.4%
522 1,776 440 374 482 527 1,823
15.2% 13.6% 12.9% 11.1% 13.0% 13.4% 12.7%

4Q19 1Q20 2Q20 3Q20 4Q20
2019 2020
4T19 1T20 2T20 3T20 4T20
1,740 6,852 1,705 1,677 1,897 1,912 7,191

-1,180 -4,723 -1,175 -1,177 -1,322 -1,318 -4,992
560 2,129 530 500 575 594 2,199
32.2% 31.1% 31.1% 29.8% 30.3% 31.1% 30.6%
-382 -1,518 -382 -371 -394 -413 -1,559
5 6 3 1 -0 7 9
183 617 151 130 181 188 649
10.5% 9.0% 8.8% 7.8% 9.6% 9.8% 9.0%
-40 -178 -60 -54 -55 -56 -225
-47 -144 -29 -27 -42 -44 -141
96 295 62 49 84 88 283
5.5% 4.3% 3.6% 2.9% 4.4% 4.6% 3.9%
274 965 240 216 269 278 1,003
15.7% 14.1% 14.1% 12.9% 14.2% 14.5% 13.9%

4Q19 1Q20 2Q20 3Q20 4Q20
2019 2020
4T19 1T20 2T20 3T20 4T20
154 543 128 48 92 117 385

-50 -176 -47 -29 -33 -43 -152
104 367 81 19 59 74 234
67.7% 67.6% 63.4% 39.8% 64.0% 63.4% 60.6%
-12 -42 -11 -13 -13 -14 -51
158 177 7 -36 -3 -51 -83
250 502 78 -30 42 10 99
162.1% 92.5% 60.6% -62.8% 45.8% 8.2% 25.8%
-31 -116 -37 -32 -33 -35 -137
-70 -120 -14 21 -3 5 9
149 266 27 -42 5 -19 -29
96.8% 49.1% 20.8% -86.9% 5.7% -16.5% -7.5%
95 337 74 10 48 64 196
81.6% 81.4% 79.2% 35.6% 70.3% 75.0% 71.2%
Includes IFRS 16 effect
Incluye efecto NIIF 16
1Q21 Q221 Q321
1T21 2T21 3T21
4,344 4,249 4,501

-3,172 -3,064 -3,232
1,172 1,185 1,269
27.0% 27.9% 28.2%
-876 -830 -860
17 -2 21
313 352 430
7.2% 8.3% 9.6%
-348 -204 -322
0 -69 -46
-35 80 62
2.9% 1.9% 1.4%
524 514 589
12.1% 12.1% 13.1%

1Q21 Q221 Q321
1T21 2T21 3T21
1,995 2,015 2,037

-1,383 -1,409 -1,407
612 605 630
30.7% 30.0% 30.9%
-467 -421 -447
-3 1 1
143 186 184
7.2% 9.2% 9.0%
-188 -51 -62
15 -46 -39
-30 89 83
-1.5% 4.4% 4.1%
291 282 287
14.6% 14.0% 14.1%

1Q21 Q221 Q321
1T21 2T21 3T21
108 120 141

-40 -40 -49
69 79 92
63.4% 66.3% 65.2%
-12 -15 -14
12 9 23
69 74 101
63.9% 61.8% 71.9%
-39 -75 -146
-9 -0 13
21 -1 -32
19.5% -1.1% -22.5%
60 68 82
75.9% 73.7% 78.1%
Cash Flow / Flujo de Caja
PEN MM
InRetail - Consolidated Cash Flow

For the nine months ended September 30, 2021 and 2020
InRetail - Flujo de Caja Consolidado
Nueve meses terminados el 30 de setiembre, 2021 y 2020
Net cash flows from operating activities

Net cash flows used in investing activities
Net cash flows used in financing activities
Net (decrease) increase of cash and short-term deposits
Cash and short–term deposits at the beginning of the period
Cash and short–term deposits at the end of the period
InRetail Pharma - Cash Flow

InRetail Pharma - Flujo de Caja

InRetail Shopping Malls - Cash Flow

InRetail Shopping Malls- Flujo de Caja

As of Sep 30 2021
Al 30 set 2021
Efectivo neto utilizado en las actividades de operación 951
Efectivo neto utilizado en las actividades de inversión -129
Efectivo neto utilizado en las actividades de financiamiento -794
Disminución neta de efectivo y depósitos a corto plazo 27
Efectivo y equivalente de efectivo al inicio del periodo 936
Efectivo y equivalente de efectivo al fin del periodo 963
As of Sep 30 2021
Al 30 set 2021
Efectivo neto utilizado en las actividades de inversión -194
Disminución neta de efectivo y depósitos a corto plazo -287
As of Sep 30 2021
Al 30 set 2021
Efectivo neto utilizado en las actividades de inversión 106
Disminución neta de efectivo y depósitos a corto plazo 183
As of Sep 30 2020
Al 30 set 2020
834
-444
-614
-225
740
515
As of Sep 30 2020
Al 30 set 2020
340
-160
-451
-272
589
318
As of Sep 30 2020
Al 30 set 2020
103
-137
32
-1
31
30
Financial Information by Segment / Información Financiera por Segmento
PEN MM
Revenues by Format
Ingresos por Formato
1Q15 2Q15 3Q15 4Q15

2015
1T15 2T15 3T15 4T15
Food Retail 973 972 984 1,149 4,077
Pharma 550 580 596 613 2,339
Shopping Malls 103 106 108 118 435
Gross Profit by Format

Utilidad Bruta por Formato
1Q15 2Q15 3Q15 4Q15

2015
1T15 2T15 3T15 4T15
Food Retail 251 250 251 313 1,065
Pharma 172 187 187 194 740
Shopping Malls 71 73 77 80 301
Gross Margin by Format

Margen Bruto por Formato
1Q15 2Q15 3Q15 4Q15

2015
1T15 2T15 3T15 4T15
Food Retail 25.8% 25.7% 25.5% 27.2% 26.1%
Pharma 31.3% 32.3% 31.3% 31.7% 31.7%
Shopping Malls 68.7% 68.7% 70.8% 68.1% 69.1%
EBITDA by Format
EBITDA por Formato
1Q15 2Q15 3Q15 4Q15
2015
1T15 2T15 3T15 4T15
Food Retail 57 52 54 96 259
Pharma 45 53 52 53 202
Shopping Malls 63 66 67 73 272
EBITDA Margin by Format

Margen EBITDA por Formato
1Q15 2Q15 3Q15 4Q15

2015
1T15 2T15 3T15 4T15
Food Retail 5.8% 5.4% 5.5% 8.3% 6.3%
Pharma 8.2% 9.2% 8.7% 8.6% 8.7%
Shopping Malls 82.9% 83.2% 81.3% 80.7% 82.8%
r Segmento
1Q16 2Q16 3Q16 4Q16 1Q17 2Q17

2016
1T16 2T16 3T16 4T16 1T17 2T17
1,038 1,005 1,018 1,179 4,241 1,151 1,101
629 644 675 676 2,624 662 661
108 111 114 125 458 112 118
1Q16 2Q16 3Q16 4Q16 1Q17 2Q17

2016
1T16 2T16 3T16 4T16 1T17 2T17
268 267 269 326 1,130 294 290
199 211 220 227 857 213 222
74 77 80 84 315 73 78
1Q16 2Q16 3Q16 4Q16 1Q17 2Q17

2016
1T16 2T16 3T16 4T16 1T17 2T17
25.8% 26.6% 26.5% 27.7% 26.7% 25.6% 26.4%
31.7% 32.7% 32.6% 33.6% 32.7% 32.1% 33.6%
68.5% 69.4% 70.3% 67.0% 68.8% 65.5% 65.8%
1Q16 2Q16 3Q16 4Q16 1Q17 2Q17
2016
1T16 2T16 3T16 4T16 1T17 2T17
64 56 59 98 277 71 63
55 61 64 61 241 52 54
67 71 74 75 286 67 71
1Q16 2Q16 3Q16 4Q16 1Q17 2Q17

2016
1T16 2T16 3T16 4T16 1T17 2T17
6.2% 5.5% 5.8% 8.3% 6.5% 6.1% 5.8%
8.7% 9.5% 9.4% 9.1% 9.2% 7.8% 8.2%
82.1% 83.1% 83.1% 80.1% 82.1% 79.3% 81.0%
3Q17 4Q17 1Q18 2Q18 3Q18 4Q18
2017
3T17 4T17 1T18 2T18 3T18 4T18
1,100 1,300 4,652 1,234 1,223 1,228 1,459
705 705 2,734 1,379 1,777 1,777 1,770
117 129 476 122 124 124 138
3Q17 4Q17 1Q18 2Q18 3Q18 4Q18

2017
3T17 4T17 1T18 2T18 3T18 4T18
290 352 1,227 312 318 328 403
232 234 901 404 490 537 503
81 87 319 83 83 84 93
3Q17 4Q17 1Q18 2Q18 3Q18 4Q18

2017
3T17 4T17 1T18 2T18 3T18 4T18
26.3% 27.1% 26.4% 25.3% 26.0% 26.7% 27.6%
32.9% 33.2% 33.0% 29.3% 27.6% 30.2% 28.4%
69.4% 67.4% 67.0% 67.8% 67.0% 67.6% 67.4%
3Q17 4Q17 1Q18 2Q18 3Q18 4Q18
2017
3T17 4T17 1T18 2T18 3T18 4T18
66 110 310 76 76 75 117
63 62 231 78 126 168 168
73 82 294 76 74 75 85
3Q17 4Q17 1Q18 2Q18 3Q18 4Q18

2017
3T17 4T17 1T18 2T18 3T18 4T18
6.0% 8.4% 6.7% 6.2% 6.2% 6.1% 8.0%
8.9% 8.7% 8.4% 5.7% 7.1% 9.5% 9.5%
79.5% 83.4% 80.9% 80.7% 79.0% 78.9% 80.0%
Excludes IFRS 16 effect Includes IFR
Excluye efecto NIIF 16 Incluye efe
1Q19 2Q19 3Q19 4Q19 1Q19
2018 2019
1T19 2T19 3T19 4T19 1T19
5,145 1,440 1,360 1,390 1,573 5,762 1,440
6,704 1,705 1,688 1,719 1,740 6,852 1,705
508 127 130 132 154 543 127

1Q19 2Q19 3Q19 4Q19 1Q19
2018 2019
1T19 2T19 3T19 4T19 1T19
1,360 363 364 365 424 1,516 363
1,935 518 511 540 561 2,130 518
343 84 87 88 104 362 85

1Q19 2Q19 3Q19 4Q19 1Q19
2018 2019
1T19 2T19 3T19 4T19 1T19
26.4% 25.2% 26.8% 26.2% 26.9% 26.3% 25.2%
28.9% 30.4% 30.3% 31.4% 32.3% 31.1% 30.4%
67.5% 65.8% 66.8% 66.8% 67.4% 66.8% 66.7%

1Q19 2Q19 3Q19 4Q19 1Q19
2018 2019
1T19 2T19 3T19 4T19 1T19
344 88 88 91 134 400 117
540 159 161 185 206 711 214
311 76 78 79 93 325 79

1Q19 2Q19 3Q19 4Q19 1Q19
2018 2019
1T19 2T19 3T19 4T19 1T19
6.7% 6.1% 6.4% 6.5% 8.5% 6.9% 8.1%
8.1% 9.3% 9.5% 10.7% 11.8% 10.4% 12.5%
79.6% 78.5% 78.0% 77.6% 79.6% 78.5% 81.6%
Includes IFRS 16 effect Includes IFRS 16 effect
Incluye efecto NIIF 16 Incluye efecto NIIF 16
2Q19 3Q19 4Q19 1Q20 2Q20 3Q20
2019
2T19 3T19 4T19 1T20 2T20 3T20
1,360 1,390 1,573 5,762 1,594 1,666 1,733
1,688 1,719 1,740 6,852 1,705 1,677 1,897
130 132 154 543 128 48 92

2Q19 3Q19 4Q19 1Q20 2Q20 3Q20
2019
2T19 3T19 4T19 1T20 2T20 3T20
364 365 424 1,516 398 435 450
511 540 560 2,129 530 500 575
88 90 104 367 81 19 59

2Q19 3Q19 4Q19 1Q20 2Q20 3Q20
2019
2T19 3T19 4T19 1T20 2T20 3T20
26.8% 26.2% 26.9% 26.3% 25.0% 26.1% 26.0%
30.3% 31.4% 32.2% 31.1% 31.1% 29.8% 30.3%
67.7% 68.2% 67.7% 67.6% 63.4% 39.8% 64.0%

2Q19 3Q19 4Q19 1Q20 2Q20 3Q20
2019
2T19 3T19 4T19 1T20 2T20 3T20
118 122 169 525 139 162 177
223 255 274 965 240 216 269
81 82 95 337 74 10 48

2Q19 3Q19 4Q19 1Q20 2Q20 3Q20
2019
2T19 3T19 4T19 1T20 2T20 3T20
8.6% 8.8% 10.7% 9.1% 8.7% 9.7% 10.2%
13.2% 14.8% 15.7% 14.1% 14.1% 12.9% 14.2%
81.1% 81.3% 81.6% 81.4% 79.2% 35.6% 70.3%
s IFRS 16 effect Includes IFRS 16 effect
4Q20 1Q21 2Q21 3Q21
2020
4T20 1T21 2T21 3T21
1,924 6,917 2,262 2,136 2,343
1,912 7,191 1,995 2,015 2,037
117 385 108 120 141

4Q20 1Q21 2Q21 3Q21
2020
4T20 1T21 2T21 3T21
515 1,798 508 517 564
594 2,199 612 605 630
74 234 69 79 92

4Q20 1Q21 2Q21 3Q21
2020
4T20 1T21 2T21 3T21
26.7% 26.0% 22.4% 24.2% 24.1%
31.1% 30.6% 30.7% 30.0% 30.9%
63.4% 60.6% 63.4% 66.3% 65.2%

4Q20 1Q21 2Q21 3Q21
2020
4T20 1T21 2T21 3T21
197 676 188 183 234
278 1,003 291 282 287
64 196 60 68 82

4Q20 1Q21 2Q21 3Q21
2020
4T20 1T21 2T21 3T21
10.3% 9.8% 8.3% 8.6% 10.0%
14.5% 13.9% 14.6% 14.0% 14.1%
75.0% 71.2% 75.9% 73.7% 78.1%
SSS - Same Store Sales / Ventas Mismas Tiendas
1Q15 2Q15 3Q15 4Q15 2015

1T15 2T15 3T15 4T15
Food Retail 3.2% 0.4% 4.4% 3.7% 3.7%
Pharmacies 13.6% 2.7% 8.5% 5.1% 5.1%
Shopping Mall Tenants 13.6% 2.7% 8.5% 5.1% 4.7%
1Q16 2Q16 3Q16 4Q16 2016 1Q17 2Q17
1T16 2T16 3T16 4T16 1T17 2T17
3.4% 0.6% 0.0% 1.0% 1.2% 7.9% 5.8%
9.0% 5.1% 7.2% 2.7% 5.9% -3.3% -5.6%
8.2% 6.3% 4.4% 2.4% 5.2% 3.1% 4.6%
3Q17 4Q17 2017 1Q18 2Q18 3Q18 4Q18
3T17 4T17 1T18 2T18 3T18 4T18
3.9% 6.0% 5.9% 4.7% 9.1% 10.2% 7.8%
-4.5% -1.2% -3.6% 4.5% 7.4% 4.7% 4.8%
1.3% 1.8% 2.6% 6.9% 5.1% 5.0% 5.8%
2018 1Q19 2Q19 3Q19 4Q19 2019 1Q20
1T19 2T19 3T19 4T19 1T20
7.9% 9.5% 4.1% 2.0% 1.5% 4.1% 7.5%
5.3% 6.3% 2.3% 2.4% -0.5% 2.6% 0.3%
5.7% 5.3% 2.9% 4.0% 1.6% 3.3% 0.7%
(1) Shopping Malls SSS from

2Q20 3Q20 4Q20 2020 1Q21 2Q21 3Q21
2T20 3T20 4T20 1T21 2T21 3T21
19.5% 23.5% 20.2% 17.7% 10.7% 5.6% 9.1%
0.2% 8.6% 8.7% 4.5% 17.8% 16.7% 4.3%
3.1% (1) -6.5% (1) 4.3% (1) 0.3%(1) 3.6%(1) 11.6%(1) 32.6%(1)
(1) Shopping Malls SSS from Q2’20 until Q3'21 only consider sales from tenants allowed to operate their physical stores.
Number of Stores and Malls / Número de Tiendas y Centros Comerciales
Supermarkets
Supermercados
2012 2013 2014
# Supermarkets # Supermercados 82 96 99
# Cash & Carry Stores # Tiendas Cash and carry
# Mass Stores # Tiendas Mass 4 2 2
# Mimarket Stores # Tiendas Mimarket
Sales Area (sqm) Sala de Ventas (m2) 225 249 270
Pharmacies
Farmacias
2012 2013 2014
# Pharmacies # Farmacias 580 725 837
Shopping Malls
Centros Comerciales
2012 2013 2014
# Shopping Malls # Centros Comerciales 13 15 17

GLA (sqm) GLA (m2) 286 399 553
os Comerciales
1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16

1T15 2T15 3T15 4T15 1T16 2T16 3T16 4T16
100 100 100 104 104 104 104 106
2 3 12 19 23 25 33 59
273 273 275 290 288 289 290 304
1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16

1T15 2T15 3T15 4T15 1T16 2T16 3T16 4T16
838 848 874 921 922 932 980 1,107
1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16

1T15 2T15 3T15 4T15 1T16 2T16 3T16 4T16
17 18 18 18 18 18 18 19
558 572 581 582 582 589 589 626
1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18
1T17 2T17 3T17 4T17 1T18 2T18 3T18 4T18
106 107 106 107 106 104 104 106
1 4
70 101 125 161 180 208 247 285
14 18
306 316 319 327 329 324 335 361
1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18

1T17 2T17 3T17 4T17 1T18 2T18 3T18 4T18
1,125 1,149 1,155 1,153 2,186 2,087 2,068 2,063
1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18

1T17 2T17 3T17 4T17 1T18 2T18 3T18 4T18
19 19 19 19 20 20 20 20
626 626 627 633 671 671 671 676
1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20
1T19 2T19 3T19 4T19 1T20 2T20 3T20 4T20
106 106 106 108 108 108 108 109
5 5 5 5 5 5 5 21 (1)
326 347 376 405 398 396 418 472
20 19 19 17 14 - - -
372 375 380 395 394 392 397 477
(1) On December 23 rd 2020 we acquired Makro Peru with 16 cash and
carry stores.
1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20

1T19 2T19 3T19 4T19 1T20 2T20 3T20 4T20
2,062 2,061 2,062 2,077 2,095 2,094 2,125 2,165
1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20

1T19 2T19 3T19 4T19 1T20 2T20 3T20 4T20
20 20 20 21 21 21 21 21
676 676 676 807 807 807 808 808
1Q21 2Q21 3Q21
1T21 2T21 3T21
109 109 109
21 21 21
472 494 516
- - -
477 476 483
1Q21 2Q21 3Q21

1T21 2T21 3T21
2,180 2,198 2,211
1Q21 2Q21 3Q21

1T21 2T21 3T21
21 21 21
808 812 834

Financial Summary Q3&#39;21

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Financial Summary Q3&#39;21

Uploaded by

Copyright:

Available Formats

Balance Sheet / Balance General

InRetail - Consolidated Balance Sheet

InRetail Pharma - Balance Sheet

InRetail Shopping Malls - Balance Sheet

InRetail - Consolidated Income Statement

InRetail Pharma - Income Statement

InRetail Shopping Malls - Income Statement

1Q15 2Q15 3Q15 4Q15 2015 1Q16 2Q16

1,611 1,645 1,674 1,868 6,798 1,765 1,746

1Q15 2Q15 3Q15 4Q15 1Q16 2Q16

103 106 108 118 435 108 111

1,794 1,968 7,273 1,913 1,865 1,912 2,120

3Q16 4Q16 1Q17 2Q17 3Q17 4Q17

662 661 705 705

3Q16 4Q16 1Q17 2Q17 3Q17 4Q17

114 125 458 112 118 117 129

7,810 2,711 3,095 3,091 3,346 12,243 3,249

2,734 1,379 1,777 1,777 1,770 6,704 1,705

476 122 124 124 138 508 127

3,156 3,221 3,444 13,070 3,249 3,156 3,221

Excludes IFRS 16 effect Includes IFRS 16 effect

1,688 1,719 1,740 6,852 1,705 1,688 1,719

Excludes IFRS 16 effect Includes IFRS 16 effect

130 132 154 543 127 130 132

3,444 13,070 3,406 3,368 3,701 3,934 14,409

es IFRS 16 effect Includes IFRS 16 effect

1,740 6,852 1,705 1,677 1,897 1,912 7,191

es IFRS 16 effect Includes IFRS 16 effect

154 543 128 48 92 117 385

4,344 4,249 4,501

Includes IFRS 16 effect

1,995 2,015 2,037

Includes IFRS 16 effect

108 120 141

InRetail - Consolidated Cash Flow

Net cash flows from operating activities

InRetail Pharma - Cash Flow

Net cash flows from operating activities

InRetail Shopping Malls - Cash Flow

Net cash flows from operating activities

1Q15 2Q15 3Q15 4Q15

Gross Profit by Format

1Q15 2Q15 3Q15 4Q15

Gross Margin by Format

1Q15 2Q15 3Q15 4Q15

EBITDA Margin by Format

1Q15 2Q15 3Q15 4Q15

1Q16 2Q16 3Q16 4Q16 1Q17 2Q17

1Q16 2Q16 3Q16 4Q16 1Q17 2Q17

1Q16 2Q16 3Q16 4Q16 1Q17 2Q17

1Q16 2Q16 3Q16 4Q16 1Q17 2Q17

3Q17 4Q17 1Q18 2Q18 3Q18 4Q18

3Q17 4Q17 1Q18 2Q18 3Q18 4Q18

3Q17 4Q17 1Q18 2Q18 3Q18 4Q18

Excludes IFRS 16 effect Includes IFR

Excludes IFRS 16 effect Includes IFR

Excludes IFRS 16 effect Includes IFR

Excludes IFRS 16 effect Includes IFR

Includes IFRS 16 effect Includes IFRS 16 effect

Includes IFRS 16 effect Includes IFRS 16 effect

Includes IFRS 16 effect Includes IFRS 16 effect

Includes IFRS 16 effect Includes IFRS 16 effect

s IFRS 16 effect Includes IFRS 16 effect

Financial Summary Q3'21

Financial Summary Q3'21